Site icon Bizon News

Free Medications for Seniors in Poland: Eligibility and Potential Changes

Poland’s program providing free medications to citizens over 65 faces scrutiny as costs reach 9 billion złoty annually, prompting a review of eligibility and drug lists.

Free Medications for Seniors: Is Everyone Eligible?

Poland’s flagship pharmaceutical refund program offers free medications to individuals over 65. However, not every senior is guaranteed to receive medications at no cost, despite thousands of drugs being covered.

To qualify, seniors must simultaneously meet three criteria, according to the Ministry of Health.

What Medications Are Covered?

Nearly 3,800 medications are currently included on the list of free drugs for seniors aged 65 and over. These include anti-allergy medications, pain relievers, hypertension treatments, diabetes and hormonal disease medications, select vaccines, and ophthalmological preparations.

A complete list of covered medications is available on the Ministry of Health website.

Prescription Requirements for Free Medications

A senior will not receive a free medication if the prescription does not include the designation “S” in the field for additional entitlements. Without this code, the medication will not be dispensed for free.

Pharmacists are not authorized to add or correct this code; they can only verify if the prescribed medication is on the list and dispense it according to refund regulations. If the code is missing or full payment (100%) is indicated, the patient will pay the standard price.

Ministry Reviewing Program and Potential Changes

The Ministry of Health has commissioned the Agency for Health Technology Assessment and Tariffication to review the list of free medications for seniors aged 65+. The goal is to assess the effectiveness of spending within the program.

This review aims to inform potential changes to the program, which currently costs approximately 9 billion złoty annually. The Ministry emphasizes this is an analysis phase, not a decision to reduce benefits.

Any potential adjustments are likely to focus on funding mechanisms and the drug list itself, rather than the fundamental right to receive free medications.

Exit mobile version